Ethrane side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Apnoea (suspension of external breathing)
2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
3. Pulmonary oedema (fluid accumulation in the lungs)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Angioedema (rapid swelling of the dermis)
2. Aortic valve sclerosis (narrowing of the aortic valve)
3. Apnoea (suspension of external breathing)
4. Aspartate aminotransferase increased
5. Blood pressure decreased
6. Cardiac arrest
7. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
8. Constipation
9. Death
10. Dizziness

female:

1. Hypoxia (low oxygen in tissues)
2. Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
3. Acute circulatory failure (shock)
4. Ammonia increased
5. Angioedema (rapid swelling of the dermis)
6. Aortic valve sclerosis (narrowing of the aortic valve)
7. Aspartate aminotransferase increased
8. Cardiac arrest
9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
10. Constipation

male:

1. Abdominal distension
2. Apnoea (suspension of external breathing)
3. Oxygen saturation decreased
4. Prothrombin level decreased
5. Pulmonary oedema (fluid accumulation in the lungs)
6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
7. Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
8. Blood pressure decreased
9. Death
10. Dizziness

0-1:

n/a

2-9:

1. Apnoea (suspension of external breathing)

10-19:

1. Ammonia increased
2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

20-29:

1. Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
2. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
3. Hypoxia (low oxygen in tissues)

30-39:

1. Hypoxia (low oxygen in tissues)
2. Acute circulatory failure (shock)
3. Apnoea (suspension of external breathing)
4. Constipation
5. Oxygen saturation decreased

40-49:

1. Dizziness
2. Hypoxia (low oxygen in tissues)

50-59:

1. Abdominal distension
2. Cardiac arrest
3. Drug ineffective
4. Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
5. Hypoxia (low oxygen in tissues)
6. Prothrombin level decreased

60+:

1. Hyperpyrexia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions- infectious)
2. Hypoxia (low oxygen in tissues)
3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
4. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
5. Angioedema (rapid swelling of the dermis)
6. Aortic valve sclerosis (narrowing of the aortic valve)
7. Aspartate aminotransferase increased
8. Haemoglobin decreased